Phacoemulsification in posterior polar cataract: Experience from a tertiary eye care Centre in North India.
FLACS
Femtosecond laser assisted cataract surgery
V groove
hydrodelineation
lambda technique
posterior polar cataract
viscodissection
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
entrez:
17
3
2020
pubmed:
17
3
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
To determine the rate of posterior capsular rupture (PCR) and assess the postoperative outcomes in patients of posterior polar cataract (PPC) undergoing phacoemulsification using a combination of "V" or "λ" nucleofractis and viscodissection. It was a retrospective study of 80 eyes of 64 patients undergoing surgery for PPC. All surgeries were performed by a single surgeon. After completion of the continuous curvilinear capsulorrhexis (CCC), controlled hydrodelineation was used to separate the endonucleus from the epinuclear shell with limited viscodissection. Phacoemulsification was then carried out by making a "V" or lambda-shaped nucleofractis with the phaco tip followed by multiple chopping of the nucleus, ensuring the integrity of the epinuclear part of the lens. The epinuclear plate was removed after viscodissection. The overall rate of PCR was 7.5% (6 out of 80 eyes). Of the 6 eyes, 4 eyes had been documented to have a pre-existing posterior capsular defect on slit-lamp examination. The rate of "on table" PCR, that is, PCR occurring intraoperatively was only 2.6% (2 of 76 eyes). Nucleus drop was not encountered in any case. Overall 87.5% eyes achieved a final visual acuity of 20/40 or better with 68.75% being 20/20 or better. Of the eyes developing PCR, two-third achieved a visual acuity of 20/30 or better. Using a combination of surgical techniques of V groove or lambda technique for nucleofractis and removal of epinucleus by viscodissection can result in a low rate of PCR and extremely good postoperative outcomes in cases of PPC.
Identifiants
pubmed: 32174575
pii: IndianJOphthalmol_2020_68_4_589_280694
doi: 10.4103/ijo.IJO_932_19
pmc: PMC7210840
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
589-594Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Ophthalmology. 2014 Oct;121(10):1915-24
pubmed: 24935281
Eye (Lond). 2006 Jul;20(7):814-6
pubmed: 16254595
J Cataract Refract Surg. 2018 Dec;44(12):1441-1445
pubmed: 30241720
J Cataract Refract Surg. 2015 Apr;41(4):702-7
pubmed: 25840293
Eye (Lond). 2008 Aug;22(8):1008-10
pubmed: 17417622
Ophthalmic Surg Lasers Imaging. 2011 Jan-Feb;42(1):78-80
pubmed: 21053813
Br J Ophthalmol. 2003 Nov;87(11):1426-7
pubmed: 14609852
J Cataract Refract Surg. 2014 Dec;40(12):2076-81
pubmed: 25465687
J Cataract Refract Surg. 1990 Mar;16(2):157-62
pubmed: 2329471
J Cataract Refract Surg. 2006 Jun;32(6):914-7
pubmed: 16814047
J Cataract Refract Surg. 2003 Jan;29(1):45-9
pubmed: 12551666
J Cataract Refract Surg. 2004 Jun;30(6):1167-9
pubmed: 15177589
J Cataract Refract Surg. 2003 Jan;29(1):16-9
pubmed: 12551661
Am J Hum Genet. 2001 Nov;69(5):1141-5
pubmed: 11577372
J Cataract Refract Surg. 2002 May;28(5):742-4
pubmed: 11978449
J Cataract Refract Surg. 1997 Jul-Aug;23(6):819-24
pubmed: 9292661
Can J Ophthalmol. 2010 Apr;45(2):154-6
pubmed: 20379301
J Refract Surg. 2015 Dec;31(12):826-8
pubmed: 26334779
Br J Ophthalmol. 2005 Feb;89(2):138-41
pubmed: 15665340
J Cataract Refract Surg. 1999 Feb;25(2):238-45
pubmed: 9951671
J Cataract Refract Surg. 2014 Dec;40(12):2148-51
pubmed: 25450246
Br J Ophthalmol. 2008 Nov;92(11):1476-8
pubmed: 18728051
Clin Exp Ophthalmol. 2010 Dec;38(9):857-61
pubmed: 20572822